Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

PML is recruited to heterochromatin during S phase and represses DAXX-mediated histone H3.3 chromatin assembly.

Shastrula PK, Sierra I, Deng Z, Keeney F, Hayden JE, Lieberman PM, Janicki SM.

J Cell Sci. 2019 Mar 26;132(6). pii: jcs220970. doi: 10.1242/jcs.220970.

PMID:
30796101
2.

Rpp29 regulates histone H3.3 chromatin assembly through transcriptional mechanisms.

Shastrula PK, Lund PJ, Garcia BA, Janicki SM.

J Biol Chem. 2018 Aug 10;293(32):12360-12377. doi: 10.1074/jbc.RA118.001845. Epub 2018 Jun 19.

PMID:
29921582
3.

Structural and functional analysis of the human POT1-TPP1 telomeric complex.

Rice C, Shastrula PK, Kossenkov AV, Hills R, Baird DM, Showe LC, Doukov T, Janicki S, Skordalakes E.

Nat Commun. 2017 Apr 10;8:14928. doi: 10.1038/ncomms14928.

4.

Examination of the metacognitive errors that contribute to anosognosia in Alzheimer's disease.

Cosentino S, Zhu C, Bertrand E, Metcalfe J, Janicki S, Cines S.

Cortex. 2016 Nov;84:101-110. doi: 10.1016/j.cortex.2016.08.003. Epub 2016 Aug 13.

PMID:
27750070
5.

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

Huntington Study Group, Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora F Jr, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Chouinard S, Beland M, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, McGarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, LaFaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E.

JAMA. 2016 Jul 5;316(1):40-50. doi: 10.1001/jama.2016.8655.

6.

RNase P protein subunit Rpp29 represses histone H3.3 nucleosome deposition.

Newhart A, Powers SL, Shastrula PK, Sierra I, Joo LM, Hayden JE, Cohen AR, Janicki SM.

Mol Biol Cell. 2016 Apr 1;27(7):1154-69. doi: 10.1091/mbc.E15-02-0099. Epub 2016 Feb 3.

7.

Aβ-related hyperactivation in frontoparietal control regions in cognitively normal elderly.

Oh H, Steffener J, Razlighi QR, Habeck C, Liu D, Gazes Y, Janicki S, Stern Y.

Neurobiol Aging. 2015 Dec;36(12):3247-3254. doi: 10.1016/j.neurobiolaging.2015.08.016. Epub 2015 Aug 24.

8.

Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.

Gu Y, Razlighi QR, Zahodne LB, Janicki SC, Ichise M, Manly JJ, Devanand DP, Brickman AM, Schupf N, Mayeux R, Stern Y.

PLoS One. 2015 Jul 29;10(7):e0123743. doi: 10.1371/journal.pone.0123743. eCollection 2015.

9.

Cerebral autoregulation, beta amyloid, and white matter hyperintensities are interrelated.

Brickman AM, Guzman VA, Gonzalez-Castellon M, Razlighi Q, Gu Y, Narkhede A, Janicki S, Ichise M, Stern Y, Manly JJ, Schupf N, Marshall RS.

Neurosci Lett. 2015 Apr 10;592:54-8. doi: 10.1016/j.neulet.2015.03.005. Epub 2015 Mar 4.

10.

HSV-1 remodels host telomeres to facilitate viral replication.

Deng Z, Kim ET, Vladimirova O, Dheekollu J, Wang Z, Newhart A, Liu D, Myers JL, Hensley SE, Moffat J, Janicki SM, Fraser NW, Knipe DM, Weitzman MD, Lieberman PM.

Cell Rep. 2014 Dec 24;9(6):2263-78. doi: 10.1016/j.celrep.2014.11.019. Epub 2014 Dec 11.

11.

Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma.

Wang R, Liu W, Helfer CM, Bradner JE, Hornick JL, Janicki SM, French CA, You J.

Cancer Res. 2014 Jun 15;74(12):3332-43. doi: 10.1158/0008-5472.CAN-13-2658. Epub 2014 Apr 15.

12.

Estrogen receptor α variants affect age at onset of Alzheimer's disease in a multiethnic female cohort.

Janicki SC, Park N, Cheng R, Clark LN, Lee JH, Schupf N.

Dement Geriatr Cogn Disord. 2014;38(3-4):200-13. doi: 10.1159/000355559. Epub 2014 Apr 8.

13.

Estrogen receptor β variants modify risk for Alzheimer's disease in a multiethnic female cohort.

Janicki SC, Park N, Cheng R, Lee JH, Schupf N, Clark LN.

J Alzheimers Dis. 2014;40(1):83-93. doi: 10.3233/JAD-130551.

PMID:
24326520
14.

The cognitive side of essential tremor: what are the therapeutic implications?

Janicki SC, Cosentino S, Louis ED.

Ther Adv Neurol Disord. 2013 Nov;6(6):353-68. doi: 10.1177/1756285613489591.

15.

Initial characterization of histone H3 serine 10 O-acetylation.

Britton LM, Newhart A, Bhanu NV, Sridharan R, Gonzales-Cope M, Plath K, Janicki SM, Garcia BA.

Epigenetics. 2013 Oct;8(10):1101-13. doi: 10.4161/epi.26025. Epub 2013 Aug 15.

16.

Seeing is believing: visualizing transcriptional dynamics in single cells.

Newhart A, Janicki SM.

J Cell Physiol. 2014 Mar;229(3):259-65. doi: 10.1002/jcp.24445. Review.

17.

Single cell analysis of RNA-mediated histone H3.3 recruitment to a cytomegalovirus promoter-regulated transcription site.

Newhart A, Rafalska-Metcalf IU, Yang T, Joo LM, Powers SL, Kossenkov AV, Lopez-Jones M, Singer RH, Showe LC, Skordalakes E, Janicki SM.

J Biol Chem. 2013 Jul 5;288(27):19882-99. doi: 10.1074/jbc.M113.473181. Epub 2013 May 20.

18.

Aromatase variants modify risk for Alzheimer's disease in a multiethnic female cohort.

Janicki SC, Park N, Cheng R, Schupf N, Clark LN, Lee JH.

Dement Geriatr Cogn Disord. 2013;35(5-6):340-6. doi: 10.1159/000343074. Epub 2013 Apr 18.

19.

Sp100A promotes chromatin decondensation at a cytomegalovirus-promoter-regulated transcription site.

Newhart A, Negorev DG, Rafalska-Metcalf IU, Yang T, Maul GG, Janicki SM.

Mol Biol Cell. 2013 May;24(9):1454-68. doi: 10.1091/mbc.E12-09-0669. Epub 2013 Mar 13.

20.

Preparation of cell lines for single-cell analysis of transcriptional activation dynamics.

Rafalska-Metcalf IU, Janicki SM.

Methods Mol Biol. 2013;977:249-58. doi: 10.1007/978-1-62703-284-1_20.

PMID:
23436368
21.

Single-cell analysis of Daxx and ATRX-dependent transcriptional repression.

Newhart A, Rafalska-Metcalf IU, Yang T, Negorev DG, Janicki SM.

J Cell Sci. 2012 Nov 15;125(Pt 22):5489-501. doi: 10.1242/jcs.110148. Epub 2012 Sep 12.

22.

Polymorphisms in HSD17B1: Early Onset and Increased Risk of Alzheimer's Disease in Women with Down Syndrome.

Lee JH, Gurney S, Pang D, Temkin A, Park N, Janicki SC, Zigman WB, Silverman W, Tycko B, Schupf N.

Curr Gerontol Geriatr Res. 2012;2012:361218. doi: 10.1155/2012/361218. Epub 2012 Mar 4.

23.

The ATM substrate KAP1 controls DNA repair in heterochromatin: regulation by HP1 proteins and serine 473/824 phosphorylation.

White D, Rafalska-Metcalf IU, Ivanov AV, Corsinotti A, Peng H, Lee SC, Trono D, Janicki SM, Rauscher FJ 3rd.

Mol Cancer Res. 2012 Mar;10(3):401-14. doi: 10.1158/1541-7786.MCR-11-0134. Epub 2011 Dec 28.

24.

Estrogen receptor-Beta variants are associated with increased risk of Alzheimer's disease in women with down syndrome.

Zhao Q, Lee JH, Pang D, Temkin A, Park N, Janicki SC, Zigman WB, Silverman W, Tycko B, Schupf N.

Dement Geriatr Cogn Disord. 2011;32(4):241-9. doi: 10.1159/000334522. Epub 2011 Dec 8.

25.

The ACF1 complex is required for DNA double-strand break repair in human cells.

Lan L, Ui A, Nakajima S, Hatakeyama K, Hoshi M, Watanabe R, Janicki SM, Ogiwara H, Kohno T, Kanno S, Yasui A.

Mol Cell. 2010 Dec 22;40(6):976-87. doi: 10.1016/j.molcel.2010.12.003.

26.

ATM-dependent chromatin changes silence transcription in cis to DNA double-strand breaks.

Shanbhag NM, Rafalska-Metcalf IU, Balane-Bolivar C, Janicki SM, Greenberg RA.

Cell. 2010 Jun 11;141(6):970-81. doi: 10.1016/j.cell.2010.04.038.

27.

Hormonal influences on cognition and risk for Alzheimer's disease.

Janicki SC, Schupf N.

Curr Neurol Neurosci Rep. 2010 Sep;10(5):359-66. doi: 10.1007/s11910-010-0122-6. Review.

28.

Single cell analysis of transcriptional activation dynamics.

Rafalska-Metcalf IU, Powers SL, Joo LM, LeRoy G, Janicki SM.

PLoS One. 2010 Apr 21;5(4):e10272. doi: 10.1371/journal.pone.0010272.

29.

Effect of adhesive matrix composition and terpinolene on indomethacin bioavailability in rats from transdermal therapeutic system.

Cal K, Sznitowska M, Janicki S.

Drug Dev Ind Pharm. 2008 Oct;34(10):1125-9. doi: 10.1080/03639040801974121 .

PMID:
18777239
30.

Show and tell: visualizing gene expression in living cells.

Rafalska-Metcalf IU, Janicki SM.

J Cell Sci. 2007 Jul 15;120(Pt 14):2301-7.

31.

Effect of azelastine, montelukast, and their combination on allergen-induced bronchoconstriction in asthma.

Richter K, Grönke L, Janicki S, Maus J, Jörres RA, Magnussen H.

Pulm Pharmacol Ther. 2008;21(1):61-6. Epub 2006 Dec 6.

PMID:
17239638
32.

Validation of the human ozone challenge model as a tool for assessing anti-inflammatory drugs in early development.

Holz O, Tal-Singer R, Kanniess F, Simpson KJ, Gibson A, Vessey RS, Janicki S, Magnussen H, Jörres RA, Richter K.

J Clin Pharmacol. 2005 May;45(5):498-503.

PMID:
15831772
33.

Dissolution test for ivermectin in oral veterinary paste.

Sznitowska M, Pietkiewicz J, Stokrocka M, Janicki S.

Pharmazie. 2004 Oct;59(10):814-5.

PMID:
15544065
34.

Dynamics of single mRNPs in nuclei of living cells.

Shav-Tal Y, Darzacq X, Shenoy SM, Fusco D, Janicki SM, Spector DL, Singer RH.

Science. 2004 Jun 18;304(5678):1797-800.

35.

Development, evaluation, and application of sediment quality targets for assessing and managing contaminated sediments in Tampa Bay, Florida.

MacDonald DD, Carr RS, Eckenrod D, Greening H, Grabe S, Ingersoll CG, Janicki S, Janicki T, Lindskoog RA, Long ER, Pribble R, Sloane G, Smorong DE.

Arch Environ Contam Toxicol. 2004 Feb;46(2):147-61.

PMID:
15106665
36.

From silencing to gene expression: real-time analysis in single cells.

Janicki SM, Tsukamoto T, Salghetti SE, Tansey WP, Sachidanandam R, Prasanth KV, Ried T, Shav-Tal Y, Bertrand E, Singer RH, Spector DL.

Cell. 2004 Mar 5;116(5):683-98.

37.

Feasibility of the Ph.Eur. flow-through cell for dissolution testing of the compounded rectal suppositories containing indomethacin or sodium diclofenac.

Woyczikowski B, Szulc J, Sznitowska M, Janicki S, Pilichowski J, Urbańska A.

Acta Pol Pharm. 2003 May-Jun;60(3):169-72. Erratum in: Acta Pol Pharm. 2003 Sep-Oct;60(5):404.

38.

Nuclear choreography: interpretations from living cells.

Janicki SM, Spector DL.

Curr Opin Cell Biol. 2003 Apr;15(2):149-57. Review.

PMID:
12648670
39.

pH-induced modifications to stratum corneum lipids investigated using thermal, spectroscopic, and chromatographic techniques.

Sznitowska M, Janicki S, Williams A, Lau S, Stołyhwo A.

J Pharm Sci. 2003 Jan;92(1):173-9.

PMID:
12486693
40.

Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma.

Kanniess F, Richter K, Janicki S, Schleiss MB, Jörres RA, Magnussen H.

Eur Respir J. 2002 Nov;20(5):1080-7.

41.

Solubilizing potential of submicron emulsions and aqueous dispersions of lecithin.

Sznitowska M, Dabrowska EA, Janicki S.

Int J Pharm. 2002 Oct 10;246(1-2):203-6.

PMID:
12270623
42.

The effect of cryoprotectants on the physical properties of large liposomes containing sodium diclofenac.

Janicki S, Jankowski J, Szulc J, Woyczikowski B, Sznitowska M.

Acta Pol Pharm. 2002 May-Jun;59(3):187-91.

43.

Physicochemical screening of antimicrobial agents as potential preservatives for submicron emulsions.

Sznitowska M, Janicki S, Dabrowska EA, Gajewska M.

Eur J Pharm Sci. 2002 Jun;15(5):489-95.

PMID:
12036725
44.

Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline.

Richter K, Janicki S, Jörres RA, Magnussen H.

Eur Respir J. 2002 May;19(5):865-71.

45.

Pharmacokinetics of verapamil and its metabolite norverapamil from a buccal drug formulation.

Sawicki W, Janicki S.

Int J Pharm. 2002 May 15;238(1-2):181-9.

PMID:
11996822
46.

[Liposomes--therapeutic progress and technological problems].

Szulc J, Dudzik M, Woyczikowski B, Sznitowska M, Janicki S.

Pol Merkur Lekarski. 2002 Feb;12(68):164-8. Review. Polish.

PMID:
11995258
47.

Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus.

Muratani M, Gerlich D, Janicki SM, Gebhard M, Eils R, Spector DL.

Nat Cell Biol. 2002 Feb;4(2):106-10.

PMID:
11753375
48.

Studies on the effect of pH on the lipoidal route of penetration across stratum corneum.

Sznitowska M, Janicki S, Baczek A.

J Control Release. 2001 Oct 19;76(3):327-35.

PMID:
11578746
49.

Evaluation of paracetamol suppositories by a pharmacopoeial dissolution test--comments on methodology.

Janicki S, Sznitowska M, Zebrowska W, Gabiga H, Kupiec M.

Eur J Pharm Biopharm. 2001 Sep;52(2):249-54.

PMID:
11522493
50.

Bioavailability of diazepam from aqueous-organic solution, submicron emulsion and solid lipid nanoparticles after rectal administration in rabbits.

Sznitowska M, Gajewska M, Janicki S, Radwanska A, Lukowski G.

Eur J Pharm Biopharm. 2001 Sep;52(2):159-63.

PMID:
11522481

Supplemental Content

Loading ...
Support Center